Cell transformation and proteome alteration in QSG7701 cells transfected with hepatitis C virus non-structural protein 3

Acta Biochimica et Biophysica Sinica

Volumn 39, Issue 10, 2007, Pages 751-762

  He, Qiongqiong ^a,b   Cheng, Ruixue ^a   Chen, Zhuchu ^a,b   Xiao, Xuxian ^a   Xiao, Zhiqiang ^b   Li, Cui ^b   Li, Bo ^a   Zhang, Pengfei ^b   Zheng, Hui ^a   Feng, Deyun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cell transformation; Hepatitis C virus; Liver neoplasm; Proteomics; Viral non structural protein

Indexed keywords

NS3 PROTEIN, HEPATITIS C VIRUS; PROTEOME; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL; ARTICLE; CELL LINE; CELL TRANSFORMATION; FEMALE; GENETIC TRANSFECTION; GENETICS; HEPATITIS C VIRUS; HUMAN; LIVER CELL; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; VALIDATION STUDY;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HEPACIVIRUS; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MICE; MICE, NUDE; PROTEOME; TRANSFECTION; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 35448998520     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2007.00344.x     Document Type: Article

References (43)

1. Houghton M. Strategies and prospects for vaccination against the hepatitis C viruses. Curr Top Microbiol Immunol 2000 242 : 327 339.
2. Iino S. Natural history of hepatitis B and C virus infections. Oncology 2002 62 : 18 23.
3. Cerni A, Chisari FV. Pathogenesis of chronic hepatitis: Immunological features of hepatic injury and viral persistence. Hepatology 1999 30 : 595 601.
4. Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 1993 67 : 1385 1395.
5. Gallinari P, Brennan D, Nardi C, Brunetti M, Tomei L, Steinkuhler C, de Francesco R. Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus. J Virol 1998 72 : 6758 6769.
6. Sakamuro D, Furukawa T, Takegami T. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol 1995 69 : 3893 3896.
7. Kwun HJ, Jung EY, Ahn JY, Lee MN, Jang KL. p53-Dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3. J Gen Virol 2001 82 : 2235 2241.
8. Fujita T, Ishido S, Muramatsu S, Itoh M, Hotta H. Suppression of actinomycin D-induced apoptosis by the NS3 protein of hepatitis C virus. Biochem Biophys Res Commun 1996 229 : 825 831.
9. Zemel R, Gerechet S, Greif H, Bachmatove L, Birk Y, Golan-Goldhirsh A, Kunin M et al. Cell transformation induced by hepatitis C virus NS3 serine protease. J Viral Hepat 2001 8 : 96 102.
10. Zemel R, Berdichevsky Y, Bachmatov, L. Z, Benhar, I, Tur-Kaspa R. Inhibition of hepatitis C virus NS3-mediated cell transformation by recombinant intracellular antibodies. J Hepatol 2004 40 : 1000 1007.
11. Siavoshian S, Abraham JD, Kieny MP, Schuster C. HCV core, NS3, NS5A and NS5B proteins modulate cell proliferation independently from p53 expression in hepatocarcinoma cell lines. Arch Virol 2004 149 : 323 336.
12. Prikhod'ko EA, Prikhod'ko GG, Siegel RM, Thompson P, Major ME, Cohen JI. The NS3 protein of hepatitis C virus induces caspase-8-mediated apoptosis independent of its protease or helicase activities. Virology 2004 329 : 53 67.
13. Borowski P, Heiland M, Feucht H, Laufs R. Characterisation of non-structural protein 3 of hepatitis C virus as modulator of protein phosphorylation mediated by PKA and PKC: Evidences for action on the level of substrate and enzyme. Arch Virol 1999 144 : 687 701.
14. Borowski P, Resch K, Schmitz H, Heiland M. A synthetic peptide derived from the non-structural protein 3 of hepatitis C virus serves as a specific substrate for PKC. Biol Chem 2000 381 : 19 27.
15. Hassan M, Ghozlan H, Abdel-Kader O. Activation of c-Jun NH2-terminal kinase (JNK) signaling pathway is essential for the stimulation of hepatitis C virus (HCV) non-structural protein 3 (NS3)-mediated cell growth. Virology 2005 333 : 324 336.
16. Feng D, Cheng R, Ouyang X, Zheng H, Tsutomu T. Hepatitis C virus nonstructural protein NS(3) and telomerase activity. Chin Med J (Engl) 2002 115 : 597 602.
17. Kim W, Oe Lim, S, Kim JS, Ryu YH, Byeon JY, Kim HJ, Kim YI et al. Comparison of proteome between hepatitis B virus- and hepatitis C virus-associated hepatocellular carcinoma. Clin Cancer Res 2003 9 : 5493 5500.
18. Le Naour, F, Brichory F, Misek DE, Bréchot C, Hanash SM, Beretta L. A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis. Mol Cell Proteomics 2002 1 : 197 203.
19. Zhu DH, Wang JB. The culture of HCC host hepatocyte QSG7701 cell line and as compared with hepatocarcinoma cell. Zhongliu Fangzhi Yanjiu 1979 5 : 7 9.
20. Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, Weiss W. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000 21 : 1037 1053.
21. Chen P, Xie JY, Liang SP. Identification of protein spots in silver-stained two-dimensional gels by MALDI-TOF mass peptide map analysis. Acta Biochim Biophys Sin 2000 32 : 387 391.
22. Kim J, Kim SH, Lee SU, Ha GH, Kang DG, Ha NY, Ahn JS et al. Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins. Electrophoresis 2002 23 : 4142 4156.
23. Ohishi M, Sakisaka S, Harada M, Koga H, Taniguchi E, Kawaguchi, T, Sasatomi et al. Detection of hepatitis-C virus and hepatitis-C virus replication in hepatocellular carcinoma by in situ hybridization. Scand J Gastroenterol 1999 34 : 432 438.
24. Pinkas J, Leder P. MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition. Cancer Res 2002 62 : 4781 4790.
25. Hamad NM, Elconin JH, Karnoub AE, Bai W, Rich JN, Abraham RT, Der CJ et al. Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev 2002 16 : 2045 2057.
26. Zhu J, Leng X, Dong N, Liu Y, Li G, Du R. Expression of mitogen- activated protein kinase and its upstream regulated signal in human hepatocellular carcinoma. Zhonghua Waike Zazhi 2002 40 : 1 16.
27. Ostrowski J, Woszczynski M, Kowalczyk P, Wocial T, Hennig E, Trzeciak L, Janik P et al. Increased activity of MAP, p70S6 and p90rs kinases is associated with AP-1 activation in spontaneous liver tumours, but not in adjacent tissue in mice. Br J Cancer 2002 82 : 1041 1050.
28. Feng DY, Zheng H, Tan Y, Cheng RX. Effect of phosphorylation of MAPK and Stat3 and expression of c-fos and c-jun proteins on hepatocarcinogenesis and their clinical significance. World J Gastroenterol 2001 7 : 33 36.
29. Tsutsumi T, Suzuki T, Moriya K, Shintani Y, Fujie H, Miyoshi, H, Matsuura et al. Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice. Hepatology 2003 38 : 820 828.
30. Zhao LJ, Wang L, Ren H, Cao J, Li L, Ke JS, Qi ZT. Hepatitis C virus E2 protein promoted human hepatoma cell proliferation through the MAPK/ERK signaling pathway via cellular receptors. Exp Cell Res 2005 305 : 23 32.
31. Park KJ, Choi SH, Choi DH, Park JM, Yie SW, Lee SY, Hwang SB. Hepatitis C virus NS5A protein modulates c-Jun N-terminal kinase through interaction with tumor necrosis factor receptor-associated factor 2. J Biol Chem 2003 278 : 30711 30718.
32. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000 24 : 227 235.
33. Boutros R, Bailey AM, Wilson SH, Byrne JA. Alternative splicing as a mechanism for regulating 14-3-3 binding: Interactions between hD53 (TPD52L1) and 14-3-3 proteins. J Mol Biol 2003 332 : 675 687.
34. Levav-Cohen Y, Haupt S, Haupt Y. Mdm2 in growth signaling and cancer. Growth Factors 2005 23 : 183 192.
35. Endo K, Ueda T, Ohta T, Terada T. Protein expression of MDM2 and its clinicopathological relationships in human hepatocellular carcinoma. Liver 2000 20 : 209 215.
36. Meyyappan M, Wong H, Hull C, Riabowol KT. Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells. Mol Cell Biol 1998 18 : 3163 3172.
37. Fishelson Z, Donin N, Zell S, Schultz S, Kirschfink M. Obstacles to cancer immunotherapy: Expression of membrane complement regulatory proteins (mCRPs) in tumors. Mol Immunol 2003 40 : 109 123.
38. Chang CC, Campoli M, Ferrone S. HLA class I defects in malignant lesions: What have we learned Keio J Med 2003 52 : 220 229.
39. Rossmanith W, Chabicovsky M, Grasl-Kraupp B, Peter B, Schausberger E, Schulte-Hermann R. Follistatin overexpression in rodent liver tumors: A possible mechanism to overcome activin growth control. Mol Carcinog 2002 35 : 1 5.
40. Liu H, Wang Y, Zhang Y, Song Q, Di C, Chen G, Tang J et al. TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun 1999 254 : 203 210.
41. Madden SL, Galella EA, Riley D, Bertelsen AH, Beaudry GA. Induction of cell growth regulatory genes by p53. Cancer Res 1996 56 : 5384 5390.
42. Dhar DK, Wang TC, Maruyama R, Udagawa J, Kubota H, Fuji T, Tachibana M et al. Expression of cytoplasmic TFF2 is a marker of tumor metastasis and negative prognostic factor in gastric cancer. Lab Invest 2003 83 : 1343 1352.
43. Seraj MJ, Samant RS, Verderame MF, Welch DR. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Res 2000 60 : 2764 2769.